Innovation project applications with a total volume of EUR 6.5 m received

PERMIDES aims to increase the innovation capability of small to medium-sized enterprises (SMEs) in the biopharma sector by means of innovation projects conducted in partnership with IT companies. These innovation projects have the objective of digitizing the value chains in the biopharma sector with the aid of IT SMEs. Funding of up to EUR 60,000 is available for each biopharma SME. Depending on the project budget, this can mean subsidies of up to 100% are granted, and for SMEs in particular this is seen as a decisive advantage over other funding schemes.

consultancy as a stimulus

An additional element are consultancy vouchers for up to EUR 5,000 each. Biopharma SMEs requiring consulting services from IT SMEs can apply for subsidies of up to EUR 12,000 for various consulting services. Unlike the abovementioned innovation vouchers, the application and assessment process for these vouchers is continuous. Consultancy Voucher applications can be submitted anytime until November 15th 2017. On average, approval of a grant is given approximately one week following receipt of the application. This short processing period and the straightforward application procedure are further factors in the overall success of PERMIDES. As before, part of the project budget also goes towards mentoring and coaching activities offered to SMEs by the participating clusters.

The PERMIDES project in brief

Eight partners including six leading biopharma and IT clusters from Germany, Austria and Norway are cooperating in the PERMIDES project with the aim to support the digitalization of the biopharma sector. PERMIDES has a total budget of EUR 4.8 million and is scheduled to run until 31 August 2018. Further applications for consultancy projects can be submitted anytime. The deadline for applications is November 15th 2017.

www.permides.eu